SNSE Sensei Biotherapeutics, Inc.
Healthcare$16.47-7.42%ClosedMarket Cap: $22.1M
As of 2026-05-26
Valuation
P/E (TTM)
—
PEG
—
P/B
0.12
P/S
-4.92
EV/EBITDA
0.69
DCF Value
$5.68
FCF Yield
-101.1%
Div Yield
0.0%
Margins & Returns
Gross Margin
2740.8%
Operating Margin
3826.9%
Net Margin
3802.5%
ROE
-283.7%
ROA
-89.8%
ROIC
-96.6%
Income Statement
Periods shown are fiscal year quarters (may differ from calendar year)
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q1 null | $0.00 | -Infinity% | $-170.6M | $-170.2M | $— | — |
| Q4 null | $0.00 | NaN% | $-5.0M | $-4.7M | $— | — |
| FY null | $0.00 | NaN% | $-22.3M | $-21.1M | $— | — |
| Q3 null | $-4.9M | 0.0% | $-4.9M | $-4.6M | $— | — |
| Q2 null | $0.00 | NaN% | $-5.2M | $-4.9M | $— | — |
| Q1 null | $0.00 | NaN% | $-7.3M | $-6.9M | $— | — |
| Q4 null | $0.00 | -Infinity% | $-7.3M | $-7.8M | $— | — |
| FY null | $0.00 | -Infinity% | $-31.7M | $-30.2M | $— | — |
| Q3 null | $0.00 | -Infinity% | $-7.8M | $-7.3M | $— | — |
| Q2 null | $0.00 | -Infinity% | $-7.8M | $-7.1M | $— | — |
| Q1 null | $0.00 | -Infinity% | $-8.7M | $-8.0M | $— | — |
| Q4 2023 | $0.00 | -Infinity% | $-8.1M | $-7.4M | $-0.30 | — |